secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0001493152-24-024888
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity raises $500K in Series B Preferred placement; up to $1.5M additional
-------------------------------------------------------------------------------

- Issued 55 Series B Preferred shares at $9,090.91 each for gross proceeds of $500,000 on June 21, 2024.
- Potential additional closings up to $1,500,000 through December 31, 2024 at investor's sole discretion.
- Series B Preferred carries 8% cumulative dividend (15% on triggering event), convertible at $3.50/share.
- Alternate conversion price at 80% (or 70% if suspended/delisted) of lowest VWAP during measuring period.
- Company must seek stockholder approval by August 15, 2024; registration rights penalty of 100,000 common shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224024888/0001493152-24-024888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224024888/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer